Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manaker, S.
Right arrow Articles by Rainbow, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manaker, S.
Right arrow Articles by Rainbow, T. C.
NEUROLOGY 1986;36:641
© 1986 American Academy of Neurology

Autoradiographic localization of thyr tropin releasing hormone receptors in human brain

Scott Manaker, Aimee Eichen, Andrew Winokur, C. Harker Rhodes and T. C. Rainbow

Departments of Biology (Dr. Manaker), Pharmacology (Drs. Eichen, Winokur, and Rainbow), Psychiatry (Dr. Winokur), and Division of Neuropathology (Dr. Rhodes), University of Pennsylvania, Philadelphia, P A.

We used quantitative autoradiography to localize thyrotropin releasing hormone (TRH) receptors in human brain. Highest concentrations of TRH receptors were localized within the cortical, basal, and lateral nuclei of the amygdala and the molecular layer of the hippocampus. Low levels were found in the cortex, diencephalon, and basal ganglia. The radioligand bound with similar affinity and pharmacology to pituitary gland as to brain. These data suggest that authentic TRH receptors in the hippocampus and amygdala may mediate the putative effects of TRH on the human brain.

Address correspondence and reprint requests to Dr. Manaker, Department of Pharmacology/G-3, University of Pennsylvania, Philadelphia, PA 19104.

Portions of this work were completed by the first author in partial fulfillment of the PhD degree from the University of Pennsylvania. Supported by Medical Scientist Training Program NIH 5-T32-GM07170 to S.M.; NIMH Research Scientist Development Award MH00044 and NIH NS 18332 to A.W.; 2-T32-NS07064 to C.H.R.; and NS 19597, NS 20006, and fellowships from the Alfred P. Sloan Foundation and the Esther A. and Joseph Klingenstein Fund to T.C.R.

Accepted for publication September 20, 1985.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
E. A. Nillni and K. A. Sevarino
The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides
Endocr. Rev., October 1, 1999; 20(5): 599 - 648.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
S. E. Molchan, A. M. Mellow, J. L. Hill, H. Weingartner, R. Martinez, B. Vitiello, and T. Sunderland
The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers
J Psychopharmacol, January 1, 1992; 6(4): 489 - 500.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.